Syngene biologics facility to be operational for US, European customers from mid-year
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
More than 10,000 scientific publications containing EUDRAGIT
The drug will target specific genetic mutations prevalent in certain types of cancers
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF
AbCellera will receive an upfront payment and is eligible to receive additional milestone payments
The institution will be spread over an area of more than 8 acres
The inspection was concluded with few procedural observations
Connecting new production and consumption areas of chilled food by low-carbon transportation services
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
Subscribe To Our Newsletter & Stay Updated